Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Anasetti

Showing results (161-170 of 222) with videos related to

Pageof 23
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1996
Allogeneic marrow transplantation for myelodysplastic syndrome with advanced disease morphology: a phase II study of busulfan, cyclophosphamide, and total-body irradiation and analysis of prognostic factorsJ E Anderson, F R Appelbaum, G Schoch, et al.
Blood|August 15, 1994
Treatment of acute graft-versus-host disease with humanized anti-Tac: an antibody that binds to the interleukin-2 receptorC Anasetti, J A Hansen, T A Waldmann, et al.
Blood|July 15, 1993
Allogeneic bone marrow transplantation for 93 patients with myelodysplastic syndromeJ E Anderson, F R Appelbaum, L D Fisher, et al.
Blood|October 15, 1990
A retrospective analysis of therapy for acute graft-versus-host disease: initial treatmentP J Martin, G Schoch, L Fisher, et al.
Blood|May 1, 1989
Influence of acute and chronic graft-versus-host disease on relapse and survival after bone marrow transplantation from HLA-identical siblings as treatment of acute and chronic leukemiaK M Sullivan, P L Weiden, R Storb, et al.
Bone Marrow Transplantation|August 22, 2002
Busulfan concentration and graft rejection in pediatric patients undergoing hematopoietic stem cell transplantationJ S McCune, T Gooley, J P Gibbs, et al.
Stem Cells (Dayton, Ohio)|January 1, 1996
Transplantation of allogeneic peripheral blood stem cells mobilized by recombinant human granulocyte colony stimulating factorW I Bensinger, R A Clift, C Anasetti, et al.
Blood|August 1, 1988
Alternating-day cyclosporine and prednisone for treatment of high-risk chronic graft-v-host diseaseK M Sullivan, R P Witherspoon, R Storb, et al.
Blood|December 9, 2000
Engraftment and survival after unrelated-donor bone marrow transplantation: a report from the national marrow donor programS M Davies, C Kollman, C Anasetti, et al.
Haematology and Blood Transfusion|January 1, 1990
Marrow grafting for acute leukemia: results and future treatment strategiesR Storb, C D Buckner, R A Clift, et al.
Pageof 23

Showing results (161-170 of 222) with videos related to

Sort By:
Pageof 23
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1996
Allogeneic marrow transplantation for myelodysplastic syndrome with advanced disease morphology: a phase II study of busulfan, cyclophosphamide, and total-body irradiation and analysis of prognostic factorsJ E Anderson, F R Appelbaum, G Schoch, et al.
Blood|August 15, 1994
Treatment of acute graft-versus-host disease with humanized anti-Tac: an antibody that binds to the interleukin-2 receptorC Anasetti, J A Hansen, T A Waldmann, et al.
Blood|July 15, 1993
Allogeneic bone marrow transplantation for 93 patients with myelodysplastic syndromeJ E Anderson, F R Appelbaum, L D Fisher, et al.
Blood|October 15, 1990
A retrospective analysis of therapy for acute graft-versus-host disease: initial treatmentP J Martin, G Schoch, L Fisher, et al.
Blood|May 1, 1989
Influence of acute and chronic graft-versus-host disease on relapse and survival after bone marrow transplantation from HLA-identical siblings as treatment of acute and chronic leukemiaK M Sullivan, P L Weiden, R Storb, et al.
Bone Marrow Transplantation|August 22, 2002
Busulfan concentration and graft rejection in pediatric patients undergoing hematopoietic stem cell transplantationJ S McCune, T Gooley, J P Gibbs, et al.
Stem Cells (Dayton, Ohio)|January 1, 1996
Transplantation of allogeneic peripheral blood stem cells mobilized by recombinant human granulocyte colony stimulating factorW I Bensinger, R A Clift, C Anasetti, et al.
Blood|August 1, 1988
Alternating-day cyclosporine and prednisone for treatment of high-risk chronic graft-v-host diseaseK M Sullivan, R P Witherspoon, R Storb, et al.
Blood|December 9, 2000
Engraftment and survival after unrelated-donor bone marrow transplantation: a report from the national marrow donor programS M Davies, C Kollman, C Anasetti, et al.
Haematology and Blood Transfusion|January 1, 1990
Marrow grafting for acute leukemia: results and future treatment strategiesR Storb, C D Buckner, R A Clift, et al.
Pageof 23